132 related articles for article (PubMed ID: 12270619)
1. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices.
Azarmi S; Farid J; Nokhodchi A; Bahari-Saravi SM; Valizadeh H
Int J Pharm; 2002 Oct; 246(1-2):171-7. PubMed ID: 12270619
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
[TBL] [Abstract][Full Text] [Related]
3. The influence of thermal treatment on the release behavior of diclofenac sodium from acrylic matrices.
Azarmi S; Farid D; Azodi-Deylami S; Ghaffari F; Nokhodchi A
Pharm Dev Technol; 2005; 10(2):233-9. PubMed ID: 15926672
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.
Quinten T; Andrews GP; De Beer T; Saerens L; Bouquet W; Jones DS; Hornsby P; Remon JP; Vervaet C
AAPS PharmSciTech; 2012 Dec; 13(4):1197-211. PubMed ID: 22965662
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
6. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
[TBL] [Abstract][Full Text] [Related]
7. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
[TBL] [Abstract][Full Text] [Related]
8. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
Grund J; Koerber M; Walther M; Bodmeier R
Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
[TBL] [Abstract][Full Text] [Related]
9. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
10. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
Billa N; Yuen KH; Peh KK
Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
Ma Y; Li WZ; Chen DW
Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
[TBL] [Abstract][Full Text] [Related]
12. [Sensitivity of cationic polymer Eudragit RL to electrolytes and its effect on drug release from Eudragit RL matrix].
Fu C; Zhao L; Jiang X
Yao Xue Xue Bao; 1998 Jul; 33(7):538-43. PubMed ID: 12016889
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.
Haznedar S; Dortunç B
Int J Pharm; 2004 Jan; 269(1):131-40. PubMed ID: 14698584
[TBL] [Abstract][Full Text] [Related]
14. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2007 Aug; 67(1):260-7. PubMed ID: 17337169
[TBL] [Abstract][Full Text] [Related]
15. Thermal treating of acrylic matrices as a tool for controlling drug release.
Hasanzadeh D; Ghaffari S; Monajjemzadeh F; Al-Hallak MH; Soltani G; Azarmi S
Chem Pharm Bull (Tokyo); 2009 Dec; 57(12):1356-62. PubMed ID: 19952444
[TBL] [Abstract][Full Text] [Related]
16. Gradation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media and conditions on release.
Donbrow M; Hoffman A; Benita S
J Microencapsul; 1995; 12(3):273-85. PubMed ID: 7650592
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
Nath B; Nath LK; Kumar P
Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
[TBL] [Abstract][Full Text] [Related]
18. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS.
Khanfar MS; Salem MS; Najib NM; Pillai GK
Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and properties of sustained-release pellets of glycyrrhizin effective components].
Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):509-13. PubMed ID: 18536370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
